|
|
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
|
1R21CA194626-01
|
$227,288
|
$227,288
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-02
|
$509,161
|
$509,161
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
|
(PQD5) Avatar-directed Treatment for Ovarian Cancer
|
5R01CA184502-02
|
$642,667
|
$642,667
|
WEROHA, SARAVUT
|
MAYO CLINIC ROCHESTER
|
|
|
2015-E03B/OVARIAN CANCER CHEMOPREVENTION (SHETA2)
|
261201500041I
|
$513,187
|
$513,187
|
UNKNOWN, UNKNOWN
|
SRI INTERNATIONAL
|
|
|
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
|
1R21CA191725-01A1
|
$223,181
|
$73,650
|
FREEDMAN, MATTHEW
|
DANA-FARBER CANCER INST
|
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
1R01CA175318-01A1
|
$354,563
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
|
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
|
4R00CA166228-03
|
$249,000
|
$249,000
|
GATZA, MICHAEL
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
5R01CA168900-04
|
$332,000
|
$166,000
|
POWELL, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
$56,557
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$2,500
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$5,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$308,175
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$114,070
|
$11,407
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
|
Addressing Psychosocial Disparities in Rural Hispanic Cancer Survivors
|
5K01CA154938-05
|
$139,976
|
$34,994
|
CEBALLOS, RACHEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-03
|
$638,721
|
$127,744
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 - 10712
|
$100,308
|
$10,031
|
Jones, Rena
|
DCEG (NCI)
|
|
|
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
|
5R01CA182832-02
|
$323,700
|
$323,700
|
MATEI, DANIELA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
An integrated systems biology approach for ovarian cancer biomarker discovery
|
3U01CA152755-05S1
|
$89,000
|
$89,000
|
DIAMANDIS, ELEFTHERIOS
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
|
Analysis of BRCA1 Recombination Functions
|
2R01CA095175-11A1
|
$330,600
|
$165,300
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
|
5R01CA181543-02
|
$397,851
|
$397,851
|
BRUGGE, JOAN
|
HARVARD MEDICAL SCHOOL
|
|
|
Analysis of the cellular secretome by targeted subcellular proteomics
|
5R21CA188945-02
|
$152,957
|
$152,957
|
RAO, BALAJI
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
|
|
Animal Model Development-CAPR infrastructure
|
ZIC BC 011137
|
$1,002,841
|
$300,852
|
Van Dyke, Terry
|
CCR (NCI)
|
|
|
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
|
5R01CA172667-03
|
$334,226
|
$334,226
|
NOMURA, DANIEL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
2R01CA135354-05
|
$380,000
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S5
|
$1,917,600
|
$249,288
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S6
|
$50,000
|
$6,500
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S7
|
$124,932
|
$16,241
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells
|
1R21CA187309-01A1
|
$214,128
|
$214,128
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
3U01CA084955-15S1
|
$18,078
|
$4,520
|
MARKS, JEFFREY
|
DUKE UNIVERSITY
|
|
|
B7-H1 Signaling in Ovarian Cancer
|
5R01CA164122-04
|
$310,213
|
$186,128
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer
|
5R42CA156933-03
|
$492,378
|
$492,378
|
KOPECEK, JINDRICH
|
THERATARGET
|
|
|
Bacterial Minicells for Cancer Therapeutics
|
5F32CA165657-02
|
$27,930
|
$9,496
|
DANINO, TAL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
|
|
Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty
|
5R21CA182715-02
|
$212,938
|
$212,938
|
FRIDLEY, BROOKE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$63,103
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$2,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$3,661
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182 - 01030
|
$62,605
|
$12,521
|
Schairer, Catherine
|
DCEG (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$76,885
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biological mechanisms involved with PDT in the treatment of MPM
|
5P01CA087971-12
|
$1,512,572
|
$378,143
|
GLATSTEIN, ELI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Biomedical Applications of Expanded Porphyrins
|
5R01CA068682-24
|
$320,588
|
$320,588
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
|
Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer
|
5R21CA185730-02
|
$207,061
|
$207,061
|
SECORD, ANGELES
|
DUKE UNIVERSITY
|
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
5R01CA157481-04
|
$311,480
|
$311,480
|
BHATTACHARYA, RESHAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
Breast and Ovary Cancer Clinical Validation Center
|
3U01CA152637-05S1
|
$93,620
|
$46,810
|
LI, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145 - 07040
|
$115,696
|
$17,354
|
Loud, Jennifer
|
DCEG (NCI)
|
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,919,499
|
$191,950
|
Restifo, Nicholas
|
CCR (NCI)
|
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-02
|
$280,000
|
$8,400
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S1
|
$62,499
|
$1,875
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S2
|
$47,351
|
$1,421
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S4
|
$31,250
|
$938
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Total relevant funding to Ovarian Cancer for this search: $92,756,286
|
